These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 28964949)

  • 41. The use of amphiphilic copolymer in the solid dispersion formulation of nimodipine to inhibit drug crystallization in the release media: Combining nano-drug delivery system with solid preparations.
    Wei MY; Lei XP; Fu JJ; Chen MY; Li JX; Yu XY; Lin YL; Liu JP; Du LR; Li X; Zhang Y; Miao YL; Huang YG; Liang L; Fu JJ
    Mater Sci Eng C Mater Biol Appl; 2020 Jun; 111():110836. PubMed ID: 32279765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
    Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
    Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic effect of Soluplus and hyaluronic acid on the supersaturation maintenance of lovastatin: The facilitated in vitro-in vivo performance and improved physical stability.
    Guan J; Liu Q; Jin L; Xu H; Wu H; Zhang X; Mao S
    Carbohydr Polym; 2019 Oct; 222():114978. PubMed ID: 31320056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Synergetic Effects of Nonpolar and Polar Protic Solvents on the Properties of Felodipine and Soluplus in Solutions, Casting Films, and Spray-Dried Solid Dispersions.
    Chen Y; Huang W; Chen J; Wang H; Zhang S; Xiong S
    J Pharm Sci; 2018 Jun; 107(6):1615-1623. PubMed ID: 29454624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kollidon® VA 64 and Soluplus® as modern polymeric carriers for amorphous solid dispersions.
    Strojewski D; Krupa A
    Polim Med; 2022; 52(1):19-29. PubMed ID: 35766434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
    Tang L; Khan SU; Muhammad NA
    Pharm Dev Technol; 2001 Nov; 6(4):531-40. PubMed ID: 11775954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions.
    Ye X; Patil H; Feng X; Tiwari RV; Lu J; Gryczke A; Kolter K; Langley N; Majumdar S; Neupane D; Mishra SR; Repka MA
    AAPS PharmSciTech; 2016 Feb; 17(1):78-88. PubMed ID: 26283197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Supersaturating drug delivery systems containing fixed-dose combination of two antihypertensive drugs: Formulation, in vitro evaluation and molecular metadynamics simulations.
    Pinto JMO; Leão AF; Bazzo GC; Mendes C; Madureira LMP; Caramori GF; Parreira RLT; Stulzer HK
    Eur J Pharm Sci; 2021 Aug; 163():105860. PubMed ID: 33901683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
    Indulkar AS; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2017 Jun; 34(6):1276-1295. PubMed ID: 28352994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluplus(®) based 9-nitrocamptothecin solid dispersion for peroral administration: preparation, characterization, in vitro and in vivo evaluation.
    Lian X; Dong J; Zhang J; Teng Y; Lin Q; Fu Y; Gong T
    Int J Pharm; 2014 Dec; 477(1-2):399-407. PubMed ID: 25445521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
    Pozzoli M; Traini D; Young PM; Sukkar MB; Sonvico F
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1510-1518. PubMed ID: 28425305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.